UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant R
Filed by a Party other than the Registrant £
Filed by a Party other than the Registrant £
Check the appropriate box:
£
|
Preliminary Proxy Statement | |
£
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
R
|
Definitive Proxy Statement | |
£
|
Definitive Additional Materials | |
£
|
Soliciting Material Pursuant to §240.14a-12 |
KB Home
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
R
|
No fee required. | |
£
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| 1) | Title of each class of securities to which transaction applies: | ||
| 2) | Aggregate number of securities to which transaction applies: | ||
| 3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||
| 4) | Proposed maximum aggregate value of transaction: | ||
| 5) | Total fee paid: | ||
£
|
Fee paid previously with preliminary materials. | |
£
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| 1) | Amount Previously Paid: | ||
| 2) | Form, Schedule or Registration Statement No.: | ||
| 3) | Filing Party: | ||
| 4) | Date Filed: | ||
Notice of 2006
KB Home Annual
Meeting of Stockholders
and Proxy Statement
KB Home Annual
Meeting of Stockholders
and Proxy Statement
April 6, 2006
KB HOME
10990 Wilshire Boulevard
Los Angeles, California 90024
(310) 231-4000
Bruce Karatz
Chairman and Chief Executive Officer
March 6, 2006
Dear Fellow Stockholder:
Your officers and directors join me in inviting you to attend
the Annual Meeting of Stockholders of KB Home at 9:00 a.m.
Pacific Daylight Time on April 6, 2006 in the Garden Room
at the Hotel Bel-Air, 701 Stone Canyon Road, in Los Angeles,
California.
The matters expected to be acted on at the meeting are described
in detail in the attached Notice of Annual Meeting of
Stockholders and Proxy Statement. In addition to specific agenda
items, by attending the Annual Meeting you will have an
opportunity to hear about our plans for the future and to meet
your officers and directors.
We look forward to seeing you on April 6.
Sincerely,
Bruce Karatz
Chairman and Chief Executive Officer
Notice of Annual Meeting
of Stockholders
|
Time and
Date:
|
9:00 a.m. Pacific Daylight Time on Thursday, April 6, 2006. | |||
|
Location:
|
Garden Room, Hotel Bel-Air, 701 Stone Canyon Road, Los Angeles, California. | |||
|
Items of
Business:
|
(1) | Elect four Class II Directors, each to serve for a three-year term; | ||
| (2) | Vote on an amendment to our Amended Certificate of Incorporation to decrease the authorized shares of our Common Stock from 300,000,000 shares to 290,000,000 shares; | |||
| (3) | Vote on the Amended and Restated KB Home 1999 Incentive Plan; | |||
| (4) | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending November 30, 2006; and | |||
| (5) | To transact any other business as may properly come before the meeting and any adjournment or postponement thereof. | |||
|
Record Date:
|
You can vote if you were a stockholder of record on February 14, 2006. | |||
|
If you attend the
Meeting:
|
If you plan to attend the meeting, you may be asked to present photo identification and you may be accompanied by only one guest. If you hold your shares in a brokerage or similar account (in street name), you will need to bring a statement reflecting the shares you owned on February 14, 2006. | |||
|
Proxy Voting:
|
Whether or not you expect to attend the meeting, please promptly complete and return the Proxy Card or voting instruction card you received to ensure that your shares will be represented. If available to you, you may also vote using the telephone number or via the Internet web site address printed on your Proxy Card or voting instruction card. | |||
|
Annual
Reports:
|
Copies of our 2005 Annual Report to Stockholders and Annual Report on Form 10-K for the fiscal year ended November 30, 2005, including audited financial statements, are being mailed to stockholders concurrently with this Proxy Statement. It is anticipated that the mailing will commence on or about March 6, 2006. | |||
By Order of the Board
of Directors,
Charles F. Carroll
Corporate Secretary
Los Angeles, California
March 6, 2006
| 10990 Wilshire Boulevard | |
| Los Angeles, California 90024 |
| Proxy Statement | |
| for | |
| Annual Meeting Of Stockholders | |
| To Be Held April 6, 2006 | |
|
|
General
Information
Why did I receive this Proxy Statement?
| Your Board of Directors is furnishing this Proxy Statement to you to solicit your proxy to be voted at our 2006 Annual Meeting of Stockholders. The Annual Meeting is scheduled for Thursday, April 6, 2006, at the time and place and for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. |
Can I attend the Annual Meeting?
You are cordially invited to attend the Annual Meeting.
Please note, however, that you may be subject to a security
check and that no cameras, recording equipment, electronic
devices, large bags, briefcases or packages will be permitted in
the Annual Meeting. Also, due to space constraints, you may be
accompanied by only one guest.
Who is entitled to vote at the Annual Meeting?
Only holders of record of the 93,180,138 shares of our
Common Stock outstanding at the close of business on
February 14, 2006 will be entitled to vote at the Annual
Meeting. Each holder of our Common Stock is entitled to one vote
for each share held. Our Grantor Stock Ownership Trust,
established to assist us in meeting certain of our obligations
to employees under our employee benefit plans, held
12,981,680 shares of our Common Stock for voting purposes
as of February 14, 2006. These shares will be voted by the
trustee of the Grantor Stock Ownership Trust in accordance with
instructions received from employees who participate in certain
of our employee benefit plans. There is no right to cumulative
voting.
Who is a Holder of Record?
If your shares of our Common Stock are registered directly in
your name with our transfer agent, Mellon Investor Services LLC,
you are considered the holder of record of those
shares. If your shares are held in a stock brokerage account or
by a financial institution or other holder of record, you are
considered the beneficial owner of those shares held in
street name.
1
How do I vote?
If you are a beneficial owner, you have the right to instruct
your broker, financial institution or other holder of record on
how to vote your shares by using the voting instruction card you
received from them or by following their respective telephone
and/or Internet voting instructions.
If you are a holder of record, you may vote by mail, by
telephone or via the Internet, as described below.
Mail. Please promptly complete and return your
Proxy Card in the postage-paid envelope provided.
Telephone. Please call the 800-number listed on
your Proxy Card. Telephone voting procedures have been
established to verify your identity, to allow you to provide
proxy voting instructions and to confirm that your instructions
were accurately recorded. Please have your Proxy Card available
when you call.
Internet. Please visit the Internet web site
address listed on your Proxy Card. As with telephone voting,
procedures have been established to verify your identity and to
confirm your voting instructions. Please have your Proxy Card
available when you visit the Internet web site address.
Telephone and Internet voting will be available to holders of
record 24 hours each day until 11:59 p.m. Eastern
Daylight Time on April 5, 2006. If you use the 800-number
or the Internet to provide your proxy voting instructions, you
do not need to mail in your Proxy Card.
Revoking Your Proxy Vote. If you are a holder of
record, you may revoke the proxy voting instructions you make by
mail, by telephone or via the Internet at any time prior to the
exercise of those instructions at the Annual Meeting by
delivering a revocation in writing to us in care of the
Corporate Secretary, KB Home, 10990 Wilshire Boulevard, Los
Angeles, California 90024.
If you are a beneficial owner, you may submit new voting
instructions by contacting your broker, financial institution or
other holder of record. You may also vote in person at the
Annual Meeting as described in the next paragraph.
In Person at the Annual Meeting. Whether you are a
holder of record or a beneficial owner you may vote in person at
the Annual Meeting, even if you have previously provided proxy
voting instructions by mail, by telephone or via the Internet.
If you are a holder of record, you may also be represented by
another person at the Annual Meeting by executing a proper proxy
designating that person. If you are a beneficial owner of
shares, you must obtain a legal proxy from your broker, bank or
other holder of record and present it with your ballot to be
able to vote in person at the Annual Meeting.
What are the voting requirements to elect the Director
nominees and to approve each of the proposals in this Proxy
Statement?
Under the laws of the State of Delaware, where we are
incorporated, stockholders may take action at the Annual Meeting
by voting their shares as described above, provided a quorum is
present. At least a majority of the outstanding shares entitled
to vote must be present or represented at the Annual Meeting to
establish a quorum. Abstentions and broker non-votes
are counted as present and entitled to vote for purposes of
establishing a quorum.
A broker non-vote arises when a broker, financial
institution or other holder of record that holds shares in
street name does not receive instructions from a beneficial
owner and does not have the discretionary authority to vote on a
particular item. Per New York Stock Exchange rules, brokers have
2
discretionary authority to vote on the election of directors and
the ratification of the appointment of the independent
registered public accounting firm. Brokers do not, however, have
discretionary authority to vote on the other two proposals in
this Proxy Statement, so broker non-votes will not be considered
entitled to vote for either such proposal and will have no
effect on the outcome.
All shares of Common Stock represented by valid proxies received
pursuant to this solicitation and not revoked will be voted in
accordance with the proxy instructions given.
Because a proxy confers discretionary authority to vote upon
other matters that may properly come before the Annual Meeting,
shares represented by valid proxies will be voted in accordance
with the judgment of Bruce Karatz, Chairman and Chief Executive
Officer, and Charles F. Carroll, Vice President, Deputy General
Counsel and Corporate Secretary, who are the persons named as
proxies on the Proxy Cards for holders of record, or their duly
authorized designees.
Where no instruction is made on a signed Proxy Card with respect
to any item submitted to a vote, such shares will be voted for
the election as Directors of the four individuals named under
Election of Directors on
pages 12 18 below, for the amendment to
our Amended Certificate of Incorporation to decrease the
authorized shares of our Common Stock from
300,000,000 shares to 290,000,000 shares discussed on
pages 19 20 below, for the Amended and
Restated KB Home 1999 Incentive Plan discussed on
pages 21 28 below and for the ratification
of the appointment of Ernst & Young LLP as our
independent registered public accounting firm for the fiscal
year ending November 30, 2006 discussed on page 29
below.
Election of Directors. The affirmative vote of a
plurality of the votes present or represented at the Annual
Meeting is required to elect each Director nominee. Accordingly,
the Director nominee with the most votes for a particular board
seat will be elected to that seat. You may vote for
all Director nominees or you may withhold your vote
with respect to one or more of the Director nominees.
Abstentions will not be counted.
Under our Governance Principles, any Director elected to the
Board of Directors at the Annual Meeting in an uncontested
election with less than the affirmative vote of a majority of
shares present in person or by proxy shall promptly tender his
or her resignation to the Chair of the Nominating and Corporate
Governance Committee of the Board of Directors (Nominating
Committee). The Nominating Committee will then promptly
evaluate all relevant factors and recommend to the full Board
whether to accept the resignation or, if appropriate, to adopt
another course of action to remedy the underlying cause(s) of
the election result. Subject to any applicable legal or
regulatory requirements, the Board shall within 90 days
following certification of the stockholder vote decide whether
to accept the resignation, reject the resignation or, if
appropriate, reject the resignation but adopt measures designed
to address the underlying cause(s) of the election result. A
full explanation of the Boards decision will be publicly
disclosed in a periodic or current report filed with the
Securities and Exchange Commission. A Director who tenders his
or her resignation because he or she was elected in an
uncontested election with less than a majority of the shares
present or represented at an Annual Meeting and any
non-independent Director will not participate in these
deliberations and decisions.
Other Proposals in this Proxy Statement. The
affirmative vote of a majority of the outstanding shares of our
Common Stock is required to approve the amendment to our Amended
Certificate of Incorporation to decrease the authorized shares
of our Common Stock from 300,000,000
3
shares to 290,000,000 shares. The affirmative vote of a majority
of the shares present or represented at the Annual Meeting and
entitled to vote is required both to approve the Amended and
Restated KB Home 1999 Incentive Plan and to ratify the
appointment of Ernst & Young LLP as our independent
registered public accounting firm for the fiscal year ending
November 30, 2006. You may vote for,
against, or abstain with respect to any
of these proposals. Abstentions will have the same effect as an
against vote.
Are the Notice of Annual Meeting, Proxy Statement, the 2005
Annual Report on
Form 10-K and the
2005 Annual Report to Stockholders available online?
Yes. The Notice of Annual Meeting, this Proxy Statement, the
2005 Annual Report on
Form 10-K and the
2005 Annual Report to Stockholders may be viewed or downloaded
from our website at: http://www.kbhome.com/investor/main.
Who will pay for this proxy solicitation?
We will pay the entire cost of soliciting proxies. In addition
to use of the mail, proxies may be solicited by our officers,
Directors and other employees by telephone, facsimile or
personal solicitation, and no additional compensation will be
paid to such individuals. We will, if requested, reimburse
banks, brokerage houses and other custodians, nominees and
certain fiduciaries for their reasonable expenses incurred in
mailing proxy material to their principals. We have hired
Georgeson Shareholder Communications Inc., a professional
soliciting organization, to assist in proxy solicitation and in
distributing proxy materials to institutions, brokerage houses,
custodians, nominees and other fiduciaries. For these services,
we will pay Georgeson a fee of $8,500.
Who will count the vote?
Representatives of our transfer agent, Mellon Investor Services
LLC, will count the votes and act as independent inspectors of
election.
4
Corporate Governance
and Board Matters
We believe that sound corporate governance is fundamental to the
success of our business and its long-term value for our
stockholders. Our Governance Principles, which are included with
this Proxy Statement at Attachment A, reflect our core
governance values and provide the framework within which we
conduct our business and pursue strategic goals. Our Governance
Principles are regularly reviewed by the Nominating and
Corporate Governance Committee of the Board of Directors, and
the full Board approves changes as appropriate.
Ethics Policy
As part of our commitment to sound governance, we expect all of
our employees and Directors to follow the highest ethical
standards when representing KB Home and our interests. To this
end, all employees, including senior management, and Directors
must abide by our Ethics Policy. Our Ethics Policy is reviewed
regularly by the Audit and Compliance Committee of the Board of
Directors, and the full Board approves changes as appropriate.
Role of the Board
The Board of Directors is elected by the stockholders to oversee
the management of our business and to assure that the long-term
interests of our stockholders are being served.
Director Qualifications
We believe that our Directors should possess the highest
personal and professional ethics, integrity, judgment and
values, and be committed to representing the long-term interests
of our stockholders. Directors should also have an inquisitive
and objective perspective, and be able and willing to dedicate
the time necessary to Board and Committee service.
The Nominating and Corporate Governance Committee of the Board
of Directors regularly assesses the skills and characteristics
of current and potential Directors in view of the perceived
needs of the Board at the time an assessment is made and may
consider the following attributes, among others:
| | Personal qualities, accomplishments and reputation in the business community; | |
| | Financial literacy, financial and accounting expertise and significant business, academic or government experience in leadership positions or at senior policy-making levels; | |
| | Geographical representation in areas relevant to our business; | |
| | Diversity of background and personal experience; | |
| | Fit of abilities and personality with those of current and potential Directors in building a Board that is effective, collegial and responsive to the needs of our business; and | |
| | Independence and an absence of conflicting time commitments. |
Director Independence
We believe that a substantial majority of our Directors should
be independent. A Director is deemed to be independent if he or
she does not have any direct or indirect material commercial or
charitable relationship with us based on all relevant facts and
circumstances. The Board of Directors makes independence
determinations annually based on information supplied by
Directors and other sources, and on the prior review and
recommendation of the Nominating and Corporate Governance
Committee of the Board of Directors.
5
The Boards Director independence determinations are guided
by certain standards which are set forth in our Governance
Principles and are consistent with New York Stock Exchange
listing standards.
Based on the Boards Director independence guidelines, the
Board has determined that all currently incumbent Directors and
Director nominees are independent, except Mr. Karatz, our
Chairman and Chief Executive Officer. In addition, the Board has
determined that all Committees of the Board, except the
Executive Committee, which does not regularly meet, are entirely
composed of independent Directors within the meaning of New York
Stock Exchange listing standards and Securities and Exchange
Commission rules. The Executive Committee is comprised of
Dr. Irani and Mr. Nogales, who are both independent,
and Mr. Karatz.
Board Meetings, Membership and Attendance
The Board held six meetings in our 2005 fiscal year. As of the
date of this Proxy Statement, the Board has 11 members.
All Directors are expected to attend our Annual Meetings. All
Directors who were serving at the time attended the 2005 Annual
Meeting, which was held on April 7, 2005.
Each Director attended at least 75% of all Board meetings and of
all meetings of the Committees on which he or she served in our
2005 fiscal year, except for Mr. Burkle, who was absent
from two Board meetings, two meetings of the Nominating and
Corporate Governance Committee and four meetings of the Audit
and Compliance Committee.
Board Committees
In our 2005 fiscal year, the Board had four committees: Audit
and Compliance; Management Development and Compensation;
Nominating and Corporate Governance and Executive. Each
Committee assists the Board in fulfilling its responsibilities,
as described below.
The chart on page 7 shows the various Committees of the
Board, the current members of those Committees, and the number
of meetings each Committee held during the year.
6
| Management | Nominating and | ||||||||||||||||
| Audit and | Development and | Corporate | |||||||||||||||
| Name of Director | Compliance | Compensation | Governance | Executive | |||||||||||||
|
Independent Directors
|
|||||||||||||||||
|
Ronald W. Burkle
|
X | X | |||||||||||||||
|
Timothy W. Finchem(a)
|
X | X | |||||||||||||||
|
Dr. Ray R. Irani
|
X | * | X | * | |||||||||||||
|
Kenneth M. Jastrow, II
|
X | ||||||||||||||||
|
James A. Johnson
|
X | X | * | ||||||||||||||
|
J. Terrence Lanni
|
X | X | |||||||||||||||
|
Melissa Lora
|
X | ||||||||||||||||
|
Michael G. McCaffery(b)
|
X | * | X | ||||||||||||||
|
Leslie Moonves
|
X | ||||||||||||||||
|
Luis G. Nogales
|
X | X | X | ||||||||||||||
|
Employee Director
|
|||||||||||||||||
|
Bruce Karatz
|
X | ||||||||||||||||
|
Number of Meetings in Fiscal 2005
|
9 | (c) | 3 | 3 | 0 | ||||||||||||
| X = Member * = Chair = Presiding Director |
| (a) | Mr. Finchem was appointed to the Board on May 11, 2005. Mr. Finchems first meeting as a member of the Nominating and Corporate Governance Committee was on October 6, 2005. Mr. Finchem was appointed to the Audit and Compliance Committee on December 8, 2005. |
| (b) | Mr. McCaffery was appointed Chair of the Audit and Compliance Committee on December 8, 2005. |
| (c) | Includes quarterly conference calls with management to review our earnings releases prior to their release. |
7
Audit and Compliance Committee. The Audit and
Compliance Committee represents and assists the Board in
fulfilling its responsibilities for oversight of our:
| | accounting and reporting practices, including the quality and integrity of our financial statements and reports; | |
| | internal control over financial reporting and disclosure controls and procedures; | |
| | audit process, including our independent registered public accounting firms qualifications, independence, retention, compensation and performance, and the performance of our internal audit department; and | |
| | compliance with legal and regulatory requirements and management of matters in which we have or may have material liability exposure. |
The Audit and Compliance Committee also oversees the preparation
of a required report for inclusion in the annual proxy statement
and is charged with the duties and responsibilities listed in
its Charter.
The Board has determined that each current member of the Audit
and Compliance Committee is independent under our Governance
Principles, New York Stock Exchange listing standards and
Securities and Exchange Commission rules. The Board has also
determined that each current member of the Audit and Compliance
Committee is financially literate under New York Stock Exchange
listing standards, and that Ms. Lora qualifies as an
audit committee financial expert under Securities
and Exchange Commission rules.
The report of the Audit and Compliance Committee is included in
this Proxy Statement on page 49 below. The Audit and
Compliance Committee Charter is included with this Proxy
Statement at Attachment B.
Management Development and Compensation Committee.
The Management Development and Compensation Committee represents
and assists the Board in fulfilling its responsibilities for
oversight of:
| | the compensation of corporate and division officers, including the determination of the nature and amount of awards to be granted under our employee compensation plans and the administration of our Chief Executive Officers Employment Agreement; and | |
| | our efforts to attract, develop and promote qualified executives. |
The Management Development and Compensation Committee also
oversees the preparation of a required report on executive
compensation for inclusion in the annual proxy statement and is
charged with the duties and responsibilities listed in its
Charter.
In addition to being independent under our Governance Principles
and New York Stock Exchange listing standards, the Board has
determined that each current member of the Management
Development and Compensation Committee is a non-employee
director under Securities and Exchange Commission rules
and an outside director under Section 162(m) of
the Internal Revenue Code.
No member of the Management Development and Compensation
Committee was part of a compensation committee
interlock during our 2005 fiscal year as described under
Securities and Exchange Commission rules. In addition, none of
our executive officers served as a director or member of the
compensation committee of another entity that would constitute a
compensation committee interlock.
8
The report of the Management Development and Compensation
Committee is included in this Proxy Statement beginning on
page 33 below.
Nominating and Corporate Governance Committee. The
Nominating and Corporate Governance Committee represents and
assists the Board in fulfilling its responsibilities to:
| | shape and monitor the implementation of our governance policies and practices; | |
| | identify and investigate individuals qualified to become Board members, consistent with criteria approved by the Board, and recommend proposed nominees for Board membership; | |
| | assess the Boards size, operations, structure, needs and effectiveness by, among other things, reviewing and making recommendations as to the membership, purpose and functions of Board Committees and overseeing the annual evaluation of the Boards and its Committees respective performance; and | |
| | establish and from time to time adjust non-employee Director compensation and benefits in accordance with, among other things, the compensation guidelines set forth in our Governance Principles. |
The Nominating and Corporate Governance Committee also reviews
and makes recommendations to the full Board on proposed changes
to our certificate of incorporation and bylaws, periodically
assesses and recommends action with respect to our stockholder
rights plan and other stockholder protections, and is charged
with the other duties and responsibilities listed in its Charter.
The Board has determined that each member of the Nominating and
Corporate Governance Committee is independent under our
Governance Principles and New York Stock Exchange listing
standards.
Executive Committee. The Executive Committee
provides Director oversight, and may act on the full
Boards behalf (except to the extent restricted by
applicable law), between regular meetings of the Board to the
extent necessary for us to operate efficiently. The Executive
Committee typically acts only pursuant to authority specifically
delegated to it by the full Board, and all actions taken by the
Executive Committee between Board meetings are considered and
ratified at the next regular meeting of the full Board. The
Executive Committee did not meet in our 2005 fiscal year, but
acted periodically by written consent.
Executive Sessions of Independent Directors
The independent Directors meet in executive sessions without
management present at least twice a year. Two executive sessions
were held in the 2005 fiscal year. The Chair of the Nominating
and Corporate Governance Committee, currently Mr. Johnson,
serves as the Boards Presiding Director and schedules and
chairs the executive sessions. The Presiding Director performs
other functions as the Board may direct. Any independent
Director can request an additional executive session.
Communications with the Board
You may write to the Board or to any of the independent
Directors c/o our Corporate Secretary at KB Home, 10990
Wilshire Boulevard, Los Angeles, California 90024. The Corporate
Secretary reviews all such written correspondence promptly upon
receipt and will forward it, as the Corporate Secretary
determines is appropriate, to a Committee Chair, individual
Director and/or to the Presiding Director. Directors who receive
such correspondence determine, individually or with other Direc-
9
tors and/or management, whether and how to respond.
Consideration of Director Candidates
The Nominating and Corporate Governance Committee is responsible
for identifying and evaluating Director candidates on the
Boards behalf. Director candidates may come to the
attention of the Nominating and Corporate Governance Committee
through current Board members, professional search firms or
other persons. These candidates are evaluated at regular or
special meetings of the Nominating and Corporate Governance
Committee, and may be considered at any point during the year.
Stockholders may recommend a candidate for the Nominating and
Corporate Governance Committees consideration by
submitting the candidates name and qualifications to the
Corporate Secretary at the address listed above under the
heading Communications with the Board. Candidates
recommended by stockholders will be evaluated in the same manner
as candidates recommended by any other person.
Director Compensation
Only non-employee Directors receive compensation for their Board
and Committee service. Non-employee Directors are compensated on
a Director Year basis, which is the period between
Annual Meetings. Accordingly, the 2005 Director
Year commenced on April 7, 2005, the date of our 2005
Annual Meeting, and will conclude on April 6, 2006, the
date of our 2006 Annual Meeting.
Non-Employee Director Compensation. Non-employee
Director compensation is currently provided under our
Non-Employee Directors Stock Plan (the Director
Plan).
The Director Plan provides each non-employee Director with an
annual cash retainer of $80,000 and an annual grant of 4,000
deferred Stock Units. Committee Chairs receive an
additional grant of Stock Units.
A Stock Unit is a contract right to receive a cash
payment equal to the fair market value of a share of our Common
Stock.
Annual Retainer. Each non-employee Director may receive
the annual cash retainer in quarterly installments of $20,000
paid out over the course of a Director Year.
Under the Director Plan, each non-employee Director may elect to
receive the annual cash retainer in Stock Units or in Stock
Options. If a Director elects to receive the annual cash
retainer in Stock Units, the Stock Units are granted at the
beginning of a Director Year at a value of 120% of the cash
value of the retainer on the day of grant.
If a non-employee Director elects to receive Stock Options in
lieu of the annual cash retainer, the Stock Options will have an
exercise price equal to the closing price of our Common Stock on
the New York Stock Exchange on the date of grant. The number of
Stock Options granted is based on the closing price of our
Common Stock on the date of grant and a Black-Scholes ratio of
25%.
Stock Options granted to a non-employee Director under the
Director Plan are fully vested when granted, but cannot be
exercised until the earlier to occur of (a) the
Directors acquisition and continued ownership of at least
5,000 shares of our Common Stock or (b) the date the
Director ceases to serve on our Board. These Stock Options have
a term of fifteen years, although they must be exercised within
one year of the date the Director ceases to serve on our Board.
Annual Stock Unit Grant. Each non-employee Director
receives an annual grant of 4,000 Stock Units at the beginning
of each Director Year. A Director may elect to receive the
annual Stock Unit
10
grant in Stock Options, which will have an exercise price equal
to the closing price of our Common Stock on the date of grant.
The number of Stock Options granted is based on the closing
price of our Common Stock on the New York Stock Exchange on the
date of grant and a Black-Scholes ratio of 25%.
Non-employee Directors are paid the equivalent of cash dividends
on their Stock Units when cash dividends are paid on our Common
Stock. The amount of these cash dividend equivalent payments is
equal to the number of Stock Units held multiplied by the amount
of the cash dividend paid on a share of our Common Stock. Stock
Units granted to a non-employee Director under the Director Plan
are paid out in cash when the Director leaves the Board, and the
amount paid is equal to the Stock Units held multiplied by the
closing price of our Common Stock on the last business day
before the payment date.
Committee Chair Retainer. At the beginning of each
Director Year, the Chair of the Audit and Compliance Committee
receives an additional annual retainer of 1,000 Stock Units, and
each Chair of the other Board Committees receives an annual
retainer of 600 Stock Units. A Committee Chair may elect to
receive the Chair Stock Unit grant in Stock Options as described
above.
Cash Election. Although the Director Plan provides the
non-employee Directors with the option to receive payout of any
Stock Units and Stock Options in shares of our Common Stock, in
December 2005 all non-employee Directors elected to receive all
payouts of such stock-based awards granted to them under the
Director Plan in cash. Accordingly, if and when made, the cash
payout of each outstanding Stock Option award under the Director
Plan will be an amount equal to the difference between the
closing price of the Common Stock on the last business day
before the payment date and the exercise price of the Stock
Option award.
Directors Legacy Program. Under our Directors Legacy
Program we will make a charitable donation on each
Directors behalf of up to $1,000,000. Each donation can be
allocated to up to five qualifying institutions or organizations
of the Directors choice upon his or her death.
To qualify to receive a donation, a recommended recipient must
be an educational institution or charitable organization which
can receive tax-deductible donations under the Internal Revenue
Code.
The Directors Legacy Program has no direct compensation value to
Directors or their families because they do not receive any cash
compensation or tax savings. Directors vest in the full donation
in five equal annual installments of $200,000, and therefore
must serve on the Board for five consecutive years to be able to
donate the maximum amount.
We fund the Directors Legacy Program through life insurance
contracts we maintain on the lives of the participating
Directors. The life insurance proceeds are expected to equal our
cost to maintain the program.
Copies of Governance Principles, Ethics Policy and Board
Committee Charters
Copies of our Governance Principles, Ethics Policy and all Board
Committee Charters can be viewed on and downloaded from our
website at http://www.kbhome.com/investor/main. Stockholders may
request free print copies of our Governance Principles, Ethics
Policy and Board Committee Charters by writing to the Corporate
Secretary at the address on page 9 above under the heading
Communications with the Board.
11
Proposals to be Voted
on
Proposal 1:
Election of
Directors
At the Annual Meeting, the Board of Directors will present as
nominees and recommend to stockholders that Messrs. Karatz,
Jastrow and McCaffery and Ms. Lora be elected as
Class II Directors to serve for a three-year term ending at
the 2009 Annual Meeting. Each nominee is currently a Director,
is standing for re-election, has consented to being nominated
and has agreed to serve as a Director if elected. Should any of
these nominees become unable to serve as a Director prior to the
Annual Meeting, the persons named on the enclosed Proxy Card
will, unless otherwise directed, vote for the election of such
other person as the Board of Directors may recommend in place of
such nominee.
Vote Required
The election of each Director nominee will require the
affirmative vote of a plurality of shares of Common Stock
present or represented at the Annual Meeting.
Your Board recommends a vote FOR the election to the
Board of each of the following nominees. A brief summary of
each nominees principal occupation, recent professional
experience and their directorships at other public companies, if
any, is provided below.
![]() |
Bruce Karatz, age 60, has been Chairman of the
Company since 1993 and Chief Executive Officer since 1986.
Mr. Karatz joined the Companys predecessor in 1972,
and from 1976 through 1980 was President of its French
homebuilding subsidiary, Kaufman & Broad S.A. From 1980
until the formation of the Company in 1986, Mr. Karatz was
President of Kaufman and Broad Development Group.
Mr. Karatz is a director of Honeywell International Inc.,
Edison International, and Kaufman & Broad S.A.
Mr. Karatz has been a Director of the Company since 1986.
12
![]() |
Kenneth M. Jastrow, II, age 58, has been
Chairman and Chief Executive Officer of Temple-Inland Inc. since
2000. Prior to that, Mr. Jastrow served as President and
Chief Operating Officer in 1998 and 1999, Group Vice President
from 1995 until 1998, and as Chief Financial Officer of
Temple-Inland from November 1991 until 1999. Mr. Jastrow is
also a director of MGIC Investment Corporation. He joined the
Board of Directors in December 2001.
Melissa Lora, age 43, is the Chief Financial Officer
of Taco Bell Corp., a position that she has held since 2001.
Ms. Lora joined Taco Bell Corp. in 1987 and has held
various positions throughout the company, most recently acting
as Regional Vice President and General Manager from 1998 to 2000
for Taco Bells operations throughout the Northeastern
United States. Ms. Lora joined the Board of Directors in
April 2004.
13
![]() |
Michael G. McCaffery, age 52, is President and Chief
Executive Officer of the Stanford Management Company, which was
established in 1991 to manage the $10.9 billion endowment
of Stanford Universitys financial and real estate
investment assets. Previously, Mr. McCaffery was Chairman
and Chief Executive Officer of Robertson Stephens Investment
Bankers, a position he held since 1993. Mr. McCaffery is a
director of Western Technology Ventures, The Investment Fund for
Foundations, RS Investment Trust and is a member of the Advisory
Board of Accel Ventures. Mr. McCaffery joined the Board of
Directors in July 2003.
14
Listed below are our other incumbent Directors and their
respective principal occupations, business affiliations and
other information for at least the past five years.
![]() |
Ron Burkle, age 53, is the founder and managing
partner of The Yucaipa Companies, a private investment firm
based in Southern California. Yucaipa specializes in
acquisitions, mergers and management of large retail,
manufacturing and distribution companies. Mr. Burkle has
served as Chairman of the Board and controlling shareholder of
numerous companies including Alliance Entertainment,
Dominicks, Fred Meyer, Ralphs and Food4Less. He is
currently a member of the board of Occidental Petroleum
Corporation, Yahoo! Inc. and Kaufman & Broad S.A., the
Companys publicly-traded French subsidiary. He has been a
Director of the Company since 1995 and his current term expires
in 2007.
Timothy W. Finchem, age 58, has been Commissioner of
the PGA TOUR since 1994. He joined the TOUR staff as Vice
President of Business Affairs in 1987, and was promoted to
Deputy Commissioner and Chief Operating Officer in 1989.
Mr. Finchem served in the White House as Deputy Advisor to
the President in the Office of Economic Affairs in 1978 and
1979, and in the 1980s co-founded the National Marketing
and Strategies Group in Washington, D.C. He joined the
Companys Board in May 2005 and his current term expires in
2008.
15
![]() |
Dr. Ray R. Irani, age 71, is Chairman,
President and Chief Executive Officer of Occidental Petroleum
Corporation. He joined Occidental in 1983 as Chairman and Chief
Executive Officer of Occidental Chemical Corporation, an
Occidental subsidiary, and as Executive Vice President of
Occidental. In 1984 he was elected to the Board of Directors of
Occidental and was named President and Chief Operating Officer.
He assumed the responsibilities of Chairman and Chief Executive
Officer in 1990, and the additional position of President in
2005. Dr. Irani was Chairman of the Board of Directors of
Canadian Occidental Petroleum Ltd., an Occidental affiliate,
from 1987 to 1999. Dr. Irani is a director of Lyondell
Chemical Company and Kaufman & Broad S.A., the
Companys publicly-traded French subsidiary. Dr. Irani
has been a Director of the Company since 1992 and his current
term expires in 2007.
James A. Johnson, age 62, has been Vice Chairman of
Perseus LLC, a merchant banking and private equity firm, since
2001. In 2000, Mr. Johnson served as Chairman and Chief
Executive Officer of Johnson Capital Partners, a private
investment company. Mr. Johnson was employed by Fannie Mae
from 1990 through 1999, where he served as Vice Chairman in
1990, Chairman and Chief Executive Officer from 1991 through
1998 and Chairman of the Executive Committee of the Board in
1999. He serves on the boards of Gannett, Inc., Target
Corporation, UnitedHealth Group, The Goldman Sachs Group, Inc.,
and Temple-Inland Inc. Mr. Johnson has been a member of the
Board of Directors since 1992 and his current term expires in
2008.
16
![]() |
J. Terrence Lanni, age 63, has been Chairman of
MGM MIRAGE since July 1995, and Chief Executive Officer from
June 1995 to December 1999, and since March 2000. Before joining
MGM MIRAGE, Mr. Lanni was President and Chief Operating
Officer of Caesars World, Inc. from April 1981 to February 1995.
Mr. Lanni has been a Director of the Company since 2003 and
his current term expires in 2008.
Leslie Moonves, age 56, has been President and Chief
Executive Officer, CBS Corporation since December 2005 when
Viacom Inc. was split into two separate companies. From 2004
until the Viacom Inc. separation, Mr. Moonves served as
Co-President and Co-Chief Operating Officer, Viacom Inc. and
Chairman of CBS. He was elevated to the position of Chairman and
Chief Executive Officer, CBS in 2003 with responsibility for UPN
after serving as President and Chief Executive Officer, CBS
Television since 1998. Mr. Moonves joined CBS in 1995 as
President, CBS Entertainment. Prior to that, Mr. Moonves
was President of Warner Bros. Television from 1993, when Warner
Bros. and Lorimar Television combined operations. From
1989-1993, he was president of Lorimar Television.
Mr. Moonves has served on the Board since 2004 and his
current term expires in 2007.
17
![]() |
Luis G. Nogales, age 62, is the Managing Partner of
Nogales Investors, LLC, a private equity investment firm. He was
Chairman and Chief Executive Officer of Embarcadero Media, Inc.
from 1992 to 1997, President of Univision Communications, Inc.,
from 1986 to 1988, and Chairman and Chief Executive Officer of
United Press International from 1983 to 1986. He is a director
of Edison International, Southern California Edison, Arbitron,
and Kaufman & Broad S.A., the Companys
publicly-traded French subsidiary. Mr. Nogales has been a
Director of the Company since 1995 and his current term expires
in 2007.
18
Proposal 2:
Approval of an
Amendment to the Amended Certificate of Incorporation
of
KB Home to decrease the
number of Authorized Shares of KB Home
Common Stock from
300,000,000 shares to 290,000,000 shares
The Board of Directors proposes to amend our Amended Certificate
of Incorporation to decrease the number of authorized shares of
our Common Stock from 300,000,000 shares to 290,000,000 shares.
This proposal fulfills a commitment we made in a March 17,
2005 letter to stockholders in connection with a proposal made
at our 2005 Annual Meeting to increase the authorized shares of
our Common Stock from 100,000,000 shares to 300,000,000 shares
(the 2005 Proposal). The primary purpose of the 2005
Proposal was to permit us to pursue a two-for-one stock split in
the form of a stock dividend to stockholders and to provide us
with sufficient authorized shares for other appropriate future
corporate purposes, as described in the 2005 Proposal.
If stockholders approved the 2005 Proposal, we committed to
propose that stockholders authorize at this Annual Meeting the
reduction of the number of authorized shares of our Common Stock
to 290,000,000 shares. We also committed not to issue
shares of our Common Stock that would cause the total number of
outstanding shares to exceed 290,000,000 shares before the
date of this Annual Meeting without first obtaining stockholder
approval.
Stockholders approved the 2005 Proposal and we effected a
two-for-one stock split of our Common Stock in the form of a
stock dividend on April 28, 2005. As of the filing date of
this Proxy Statement, we have not issued shares of our Common
Stock to cause the total number of outstanding shares to exceed
290,000,000 shares, and we do not intend to do so prior to
the date of the Annual Meeting.
In order to fulfill our commitment, the Board adopted the
following proposed amendment to our Amended Certificate of
Incorporation at its February 9, 2006 meeting, subject to
stockholder approval, and declared the proposed amendment to be
advisable:
| RESOLVED, that the Amended Certificate of Incorporation of the Corporation be amended to decrease the authorized shares of Common Stock and for this purpose Paragraph (a) of Article Fourth thereof shall be struck out in its entirety and shall be replaced with the following new Paragraph (a) of Article Fourth: | |
| FOURTH: (a) The total number of shares of stock which the Corporation shall have authority to issue is 325,000,000, consisting of 290,000,000 shares of Common Stock, par value $1.00 per share (the Common Stock), 25,000,000 shares of Special Common Stock, par value $1.00 per share (the Special Common Stock) and 10,000,000 shares of Preferred Stock, par value $1.00 per share (the Preferred Stock). |
Current Capital Structure
As of the February 14, 2006 record date
93,180,138 shares of our Common Stock were issued and
outstanding, including 12,981,680 shares held by our Grantor
Stock Ownership Trust and excluding 21,020,516 shares of Common
19
Stock held in treasury. There were 13,268,412 shares of
Common Stock reserved for issuance upon exercise of outstanding
stock options and stock options and stock awards that may be
granted in the future under our equity compensation and
incentive plans. Accordingly, there are 172,530,934 authorized
shares of Common Stock currently available for issuance. There
are no shares of Special Common Stock or Preferred Stock
currently outstanding.
Impact of Proposed Amendment
The proposed amendment would decrease the total number of
authorized shares of our Common Stock by 10,000,000 shares.
The proposed amendment would not change any of the current
rights and privileges of our Common Stock or its par value. In
addition, the proposed amendment would not in any way limit our
ability to use the authorized shares of our Common Stock for
appropriate future corporate purposes (which would not require
further stockholder action or approval), including paying future
stock dividends, raising capital through Common Stock offerings,
funding future employee benefit plan obligations and issuing
Common Stock in acquisitions or other strategic transactions.
The proposed amendment would also not limit in any way our
ability to use the authorized shares of our Common Stock to
oppose hostile takeover attempts or to delay or prevent a change
in control of us. We have no present intention to issue or use
shares of our Common Stock for such purposes, and we are not
currently aware of any takeover attempt or potential change of
control.
Based on the foregoing and our prior commitment, the Board
believes it is desirable and in our and our stockholders
best interests at this time to adopt the proposed amendment to
reduce our authorized shares of Common Stock from
300,000,000 shares to 290,000,000 shares.
Vote Required
Approval of the proposed amendment to our Amended Certificate of
Incorporation req






